|
FY2025
12 months to Jan 31, 2026
|
FY2024
12 months to Feb 1, 2025
|
FY2023
12 months to Feb 3, 2024
|
FY2022
12 months to Jan 28, 2023
|
FY2021
12 months to Jan 29, 2022
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization of property and equipment | |||||
| Amortization of debt issuance costs | |||||
| Gain on sale of assets | |||||
| Deferred income tax provision | |||||
| Stock-based compensation expense | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Inventories | |||||
| Accounts receivable | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Income taxes payable | |||||
| Accrued expenses and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash Flows from Investing Activities: | |||||
| Capital expenditures | |||||
| Proceeds from sale of property and equipment | |||||
| Purchases of investments | |||||
| Maturities of investments | |||||
| Net cash used in investing activities | |||||
| Cash Flows from Financing Activities: | |||||
| Repayments on finance leases | |||||
| Payment of debt issuance costs | |||||
| Proceeds from stock option exercises | |||||
| Common shares withheld for taxes | |||||
| Payment for shares repurchased | |||||
| Net cash used in financing activities | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of the period | |||||
| Cash and cash equivalents, end of the period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid during the year for: | |||||
| Interest | |||||
| Income taxes | |||||
| Non-cash investing activities: | |||||
| Accrued purchases of property and equipment | |||||
Loading...